{
    "clinical_study": {
        "@rank": "132806", 
        "acronym": "MOZArT", 
        "arm_group": [
            {
                "arm_group_label": "Co-administered Traumeel\u00ae and Zeel\u00ae", 
                "arm_group_type": "Experimental", 
                "description": "Injection volume is 4.2 mL for active study medication (2.0 mL Zeel plus 2.2 mL Traumeel in one intra articular (IA) injection) on treatment days 1, 8 and 15."
            }, 
            {
                "arm_group_label": "Placebo injectable solution", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Injection volume of placebo is 4.2 mL as well (taken from the 10.0 mL vial by unblinded staff member, rest to be kept for drug accountability)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate the effectiveness and safety of a combined Traumeel\u00ae\n      /Zeel\u00ae injection against placebo in patients with moderate-to-severe pain associated with\n      osteoarthritis of the knee."
        }, 
        "brief_title": "Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Moderate-to-severe Pain Associated With Osteoarthritis of the Knee", 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Knee"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Screening Inclusion Criteria (Visit 1):\n\n          1. OA of the knee by American College of Rheumatology criteria\n\n          2. Men or women between 45-80 years of age.\n\n          3. Have documented diagnosis of primary OA of the target knee based on clinical and\n             radiographic criteria (Kellgren-Lawrence Numerical Grading System of Grade 2-3) in\n             the tibial-femoral compartment of the target knee confirmed by standard post-anterior\n             weightbearing X-ray of the knee in full extension taken </= 6 months prior to Visit\n             1.\n\n          4. Currently taking an Nonsteroidal anti-inflammatory drug (NSAID), or acetaminophen on\n             a regular basis (4-7 days/ week) over last 2 weeks prior to Visit 1 and has\n             experienced amelioration of pain on these medications.\n\n          5. Must have a 50-foot walk test pain score of less than 40 mm on a 100 mm VAS in the\n             target knee at screening\n\n          6. Pain in the non-target (contralateral) knee must not be greater than 30 mm on a 100\n             mm VAS on 50-foot walk test, and the target knee must be more symptomatic.\n\n          7. Willingness to stop all OA treatments.\n\n          8. Fully informed of the risks of entering the study and willing to provide written\n             consent to enter the study.\n\n          9. Able to understand and be willing to comply with all study requirements, particularly\n             the weekly injection regimen for administration of study drug.\n\n        Baseline Inclusion Criteria for Randomization (Visit 3):\n\n        1. Primary complaint is pain immediately following an unassisted 50-foot walk. They must\n        show:\n\n          1. moderate to severe pain score in the target knee as demonstrated by 40 - 90 mm\n             recorded on a 100 mm VAS, and\n\n          2. 20 mm increase in pain from their screening visit pain score (a \"flare\")\n\n          3. pain in the non-target (contralateral) knee must </= 30 mm on a 100 mm VAS\n\n        Exclusion Criteria:\n\n          1. Known hypersensitivity or allergy to any of the components of Traumeel or Zeel\n\n          2. Known hypersensitivity or allergy to acetaminophen.\n\n          3. Has body mass index (BMI) >38 kg/m2.\n\n          4. Avoidance of, or aversion to, nonprescription medications.\n\n          5. Clinical symptoms of meniscal instability or significant valgus/ varus that requires\n             corrective osteotomy\n\n          6. Has had any major injury or surgery to the target knee in the prior 12 months.\n\n          7. Has one or a combination of the following co-morbidities:\n\n               1. other inflammatory arthropathies, gout or pseudogout within previous 6 months\n\n               2. avascular necrosis\n\n               3. severe bone or joint deformity in target knee\n\n               4. osteonecrosis of either knee\n\n               5. fibromyalgia\n\n               6. pes anserine bursitis\n\n               7. lumbar radiculopathy with referred pain to either knee\n\n               8. neurogenic or vascular claudication\n\n               9. significant anterior knee pain due to diagnosed isolated patella-femoral\n                  syndrome in the target knee\n\n              10. target knee joint infection or skin disorder/infection to the area surrounding\n                  the knee within previous 6 months\n\n              11. current treatment or treatment of cancer within the previous 2 years (excluding\n                  basal cell or squamous cell carcinoma of the skin)\n\n          8. Has participated in any experimental drug or device study within the prior one (1)\n             month and/or IA injections six (6) months.\n\n          9. Has referred pain from other joints\n\n         10. Has significantly debilitating concurrent infection(s)\n\n         11. Significant ligamentous instability\n\n         12. Any prior viscosupplementation therapy (in target knee) within 6 months prior to\n             Screening\n\n         13. Systemic or IA injection of corticosteroids in any joint within 3 months of enrolment\n\n         14. Therapy with oral hyaluronic acid products, and/or oral pharmaceutical products\n             containing glucosamine and/or chondroitin sulphate and/or diacerein\n\n         15. Therapy with opioids within the last 90 days including intra-dermal delivery systems\n             (patches)\n\n         16. Therapy with autologous stem cells\n\n         17. Therapy with coumarins such as warfarin, Coumadin; heparin and derivative substances\n             including low molecular weight heparin, synthetic pentasaccharide inhibitors of\n             factor Xa such as fondaparinux and idraparinux; direct factor Xa inhibitors such as\n             rivaroxaban and apixaban; direct thrombin inhibitors such as hirudin, lepirudin,\n             bivalirudin, argatroban and dabigatran.\n\n         18. Concomitant inflammatory or other rheumatologic, neurological or cardiovascular\n             diseases which could affect the evaluation of knee pain\n\n         19. Ongoing litigation for workers compensation for musculoskeletal injuries or disorders\n\n         20. Use of alcohol of more than 4 drinks per day\n\n         21. Clinically important axial deviation (varus, valgus) greater than 15 degrees\n\n         22. Concomitant severe OA of the hip or other joints, which might interfere with the\n             assessments required by the study\n\n         23. Painful knee conditions other than OA (e.g., Paget's disease)\n\n         24. Hemiparesis of lower limbs\n\n         25. Significant planned surgery to lower limbs, which might interfere with the patient's\n             ability to comply with study requirements\n\n         26. Presence of serious gastrointestinal, renal, hepatic, pulmonary, cardiovascular,\n             neurological disease that might interfere with the outcome of the study or the\n             patient's ability to comply with study requirements\n\n         27. Presence of infections and/or skin diseases in the area of the injection site such as\n             psoriasis\n\n         28. Females who are pregnant or breast-feeding or not using recognized effective\n             contraceptive measures. Females of childbearing potential (including those less than\n             one year post-menopausal) must agree to maintain reliable birth control throughout\n             the study, i.e., an established use of oral, injected or implanted hormonal\n             contraception, female sterilization by hysterectomy, bilateral oophorectomy, or\n             bilateral tubal exeresis, intrauterine device (IUD) or coil or barrier method (e.g.,\n             diaphragm, cervical/ vault cap) plus spermicidal cream/ gel\n\n         29. Clinically significant abnormal laboratory values (as judged by the investigator) at\n             the Screening visit\n\n         30. Patients who are likely to be non-compliant or uncooperative during the study, as\n             judged by the investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01887678", 
            "org_study_id": "C1301"
        }, 
        "intervention": [
            {
                "arm_group_label": "Co-administered Traumeel\u00ae and Zeel\u00ae", 
                "description": "Injection volume is 4.2 mL for active study medication (2.0 mL Zeel plus 2.2 mL Traumeel in one IA injection) on treatment days 1, 8 and 15.", 
                "intervention_name": "Traumeel\u00ae / Zeel\u00ae Injectable Solution", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo injectable solution", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 15, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85050"
                    }, 
                    "name": "Clinical Research Advantage - Arizona II"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85712"
                    }, 
                    "name": "Tucson Orthopaedic Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dinuba", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93618"
                    }, 
                    "name": "Universal BioPharma Research Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "N. Hollywood", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91606"
                    }, 
                    "name": "Providence Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Barbara", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93108"
                    }, 
                    "name": "Hans Richard Barthel, M.D., Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westlake Village", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91361"
                    }, 
                    "name": "Westlake Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80239"
                    }, 
                    "name": "Radiant Research Inc. - Denver"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edgewater", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32132"
                    }, 
                    "name": "Riverside Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33155"
                    }, 
                    "name": "AppleMed Research, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pinellas Park", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33781"
                    }, 
                    "name": "Radiant Research Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boise", 
                        "country": "United States", 
                        "state": "Idaho", 
                        "zip": "83713"
                    }, 
                    "name": "Injury Care Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evansville", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47714"
                    }, 
                    "name": "Global Scientific Innovations"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "Sundance Clinical Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10022"
                    }, 
                    "name": "Research Across America - NY"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Manhattan Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cary", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27518"
                    }, 
                    "name": "PMG Cary Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28204"
                    }, 
                    "name": "New Hope Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28209"
                    }, 
                    "name": "PMG Research of Charlotte"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27609"
                    }, 
                    "name": "PMG Research of Raleigh"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salisbury", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28144"
                    }, 
                    "name": "PMG Research of Salisbury"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44311"
                    }, 
                    "name": "Radiant Research Inc. - Akron"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45246"
                    }, 
                    "name": "Sterling Research Group, Ltd"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45431"
                    }, 
                    "name": "Clinical Inquest Center Ltd."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73119"
                    }, 
                    "name": "Hillcrest Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Altoona", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16602"
                    }, 
                    "name": "Blair Orthopedic Associates, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Franklin", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37064"
                    }, 
                    "name": "Clinical Research Solutions"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37938"
                    }, 
                    "name": "PMG Research of Knoxville"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37912"
                    }, 
                    "name": "PMG Research of Knoxville"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Smyrna", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37167"
                    }, 
                    "name": "Clinical Research Solutions"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84123"
                    }, 
                    "name": "Radiant Research Inc. - Salt Lake City"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multi-center Double-blind, Randomized, Controlled Trial to Evaluate the Effectiveness and Safety of Co-administered Traumeel\u00ae and Zeel\u00ae Intra-articular Injections Versus Placebo Intra-articular Injections in Patients With Moderate-to-Severe Pain Associated With Osteoarthritis of the Knee", 
        "other_outcome": [
            {
                "measure": "Each Adverse Event (AE)", 
                "safety_issue": "Yes", 
                "time_frame": "Starting at Visit 2/ Start of Lead-In period (Day 7 up to day 119)"
            }, 
            {
                "measure": "Incidence of Treatment Emergent Adverse Events (TEAEs)", 
                "safety_issue": "Yes", 
                "time_frame": "during the treatment period and follow up period (Days 11 to 119)"
            }, 
            {
                "measure": "Any TEAEs within each body system", 
                "safety_issue": "Yes", 
                "time_frame": "during the treatment period and follow up phase (Days 11 to 119)"
            }, 
            {
                "measure": "Proportion of patients who discontinued due to an AE", 
                "safety_issue": "Yes", 
                "time_frame": "All visits (Days 1 up to 119)"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "Tucson Orthopaedic Institute", 
                "last_name": "Nebojsa Skrepnik, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clinical Research Advantage - Arizona II", 
                "last_name": "Royal Anspach, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hans Richard Barthel, M.D., Inc.", 
                "last_name": "Hans Barthel, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Westlake Medical Research", 
                "last_name": "Shariar Cohen-Gadol, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Radiant Research Inc. - Denver", 
                "last_name": "David Bolshoun, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Radiant Research Inc", 
                "last_name": "Linda Murray, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Riverside Clinical Research", 
                "last_name": "Susan Hole, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "AppleMed Research, Inc.", 
                "last_name": "Agustin Latorre, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Injury Care Medical Center", 
                "last_name": "Richard Radnovich, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Global Scientific Innovations", 
                "last_name": "Moges Sisay, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sundance Clinical Research, LLC", 
                "last_name": "Larkin T Wadsworth, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "New Hope Clinical Research", 
                "last_name": "Kurian Abraham, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PMG Research of Salisbury", 
                "last_name": "Rakesh Patel, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PMG Research of Charlotte", 
                "last_name": "George Raad, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PMG Cary Medical Research", 
                "last_name": "Martin VanCleeff, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PMG Research of Raleigh", 
                "last_name": "John Rubino, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Research Across America - NY", 
                "last_name": "Howard R Adelglass, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Manhattan Medical Research", 
                "last_name": "Louis Re, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clinical Inquest Center Ltd.", 
                "last_name": "Daniel Whitmer, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Radiant Research Inc. - Akron", 
                "last_name": "Jeffrey Klein, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sterling Research Group, Ltd.", 
                "last_name": "Rakesh Davit, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hillcrest Clinical Research", 
                "last_name": "Glenn Smith, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Blair Orthopedic Associates, Inc", 
                "last_name": "Shawn Saylor, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clinical Research Solutions", 
                "last_name": "Alex Slandzicki, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clinical Research Solutions", 
                "last_name": "Sadia Dar, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PMG Research of Knoxville", 
                "last_name": "Rickey Manning, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PMG Research of Knoxville", 
                "last_name": "Paul Wakefield, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Radiant Research Inc. - Salt Lake City", 
                "last_name": "Michael R Adams, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Providence Clinical Research", 
                "last_name": "Teresa Sligh, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universal BioPharma Research Inc.", 
                "last_name": "David. Cardona, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in knee pain as measured by the WOMAC Osteoarthritis (OA) Index Pain Subscale (Section A, Items #1-5) measured by 100 mm VAS", 
            "safety_issue": "No", 
            "time_frame": "from Baseline (Day 1, predose) to End of Study Visit (up to Day 119)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01887678"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pain subscore (WOMAC Section A, Items #1-5) measured by 100 mm VAS", 
                "safety_issue": "No", 
                "time_frame": "from Baseline to post-Baseline visits except End of Study Visit (up to day 105)"
            }, 
            {
                "measure": "physical function subscore (WOMAC Section C, Items #8-24) recorded on 100 mm VAS", 
                "safety_issue": "No", 
                "time_frame": "from Baseline (Day 1, predose) to End of Study Visit (up to Day 119)"
            }, 
            {
                "measure": "total WOMAC score (all subscales) recorded on 100 mm VAS", 
                "safety_issue": "No", 
                "time_frame": "from Baseline (Day 1, predose) to End of Study Visit (up to Day 119)"
            }, 
            {
                "measure": "patient global assessment (PGA) and physician global assessment (PhGA)", 
                "safety_issue": "No", 
                "time_frame": "from Baseline (Day 1, predose) to End of Study Visit (up to Day 119)"
            }, 
            {
                "measure": "pain immediately following the 50-foot walk (100 mm VAS)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (Day 1, predose) to post-Baseline visits (up to day 119)"
            }, 
            {
                "measure": "time to walking (50-foot walk test)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (Day 1, predose) to post-Baseline visits (up to day 119)"
            }, 
            {
                "measure": "time to 50% pain relief (study population measure statistically derived)", 
                "safety_issue": "No", 
                "time_frame": "Statistically derived"
            }, 
            {
                "measure": "time to 100% pain relief (study population measure statistically derived)", 
                "safety_issue": "No", 
                "time_frame": "Statistically derived"
            }, 
            {
                "measure": "time to and use of rescue medication (acetaminophen up to 3000 mg per day for breakthrough pain) (study population measure statistically derived)", 
                "safety_issue": "No", 
                "time_frame": "Statistically derived"
            }, 
            {
                "measure": "stiffness subscore (WOMAC Section B, Items #6-7) measured by 100 mm VAS", 
                "safety_issue": "No", 
                "time_frame": "from Baseline (Day 1, predose) to End of Study Visit (up to Day 119)"
            }
        ], 
        "source": "Biologische Heilmittel Heel GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biologische Heilmittel Heel GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}